Myopia.Care Presents a Customized Update for Switzerland

The absolute highlight of the new version is the integration of the MiGeL limit for myopia management in health insurance. The digital risk analysis significantly simplifies and standardizes the assessment and communication process.

The update includes evidence-based tools for clinical analysis and counseling:

The highlight for Switzerland: The new growth curve with integrated MiGeL limitation. To guide decisions regarding the start of therapy and the choice of treatment strategy, the new growth curve illustrates the axial length of the child’s eye in relation to age. Specialists can immediately see which risk category the patient’s eye length falls into. The progression of actual values is displayed and can be compared to a virtual, untreated progression since the start of therapy. The key advantage for Swiss users: The growth curve recommended by the SOG for assessing MiGeL (List of Medicines and Medical Devices) limitations has been integrated into this growth curve. This significantly simplifies the necessary documentation required under Swiss reimbursement guidelines and provides parents with certainty regarding billing and progress documentation.

In addition, the updated user interface offers the following additional features:

1. MyAppia for Predicting Myopia Progression

The MyAppia curve illustrates to parents and patients the expected progression of myopia up to age 17. The calculations are based on current study data and the individual’s risk factor. Actual measurements are displayed over time and can be directly compared with the predicted effects of the selected treatment options.

2. Objective Assessment Based on Annual Eye Length Growth

To objectively assess treatment success over time and adjust the therapy as needed, this graph compares annual axial length growth with physiological growth and potential, untreated myopic growth. To simplify the evaluation, calculations of treatment success are displayed for each case.

3. Digitally Connected Myopia Report for Easy MiGeL Documentation

At the end of the consultation, you can generate a Myopia Report that includes your company’s information and custom text. Combined with the new update, this report offers a significant advantage: it makes it particularly easy to prepare and share the data required for MiGeL coverage. The report can be printed out in the traditional way, and the various charts can be shared digitally via a patient QR code. This allows parents—and, if necessary, other relevant parties—to conveniently access the progress records and charts from home on their smartphone or desktop at any time.

Since 2014, Myopia.Care has been supporting eye care specialists and patients on their journey in myopia management. Today, Myopia.Care brings together an international community of over 2,000 specialists from more than 50 countries. Myopia.Care has remained independent throughout the years—and it is precisely this independence that enables the company to consistently tailor innovations to the needs of eye care practices and country-specific requirements.

With Myopia.Care, professionals have all the tools they need for professional, evidence-based myopia management in one place. Myopia.Care offers the MyoCalc curves in a free version as well as an enhanced Pro version that provides additional features.

Source: www.myopiacare.com